arBtrage CAPITALIZING MARKETS checking… Sign in

LENZ Therapeutics, Inc.

LENZ Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$7.01
▼ -2.6% Today
as of Jun 7, 07:19 ET
Last 30 days -24.54% Apr 28 → Jun 05
$6.38 $7.37 $8.36 $9.34 $10.33 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$7.19
High
$7.36
Low
$6.92
Volume
$492,606
Avg Vol
$867,589
Mkt Cap
$251M
P/E (TTM)
Beta
52w High
$50.40
52w Low
$6.61
Div Yield
Shares Out
$31M

Overview

52-week range
$6.61
$50
1% of range
Avg surprise (last 2)
-8.2%
Avg reaction (last 2)
-1.4%
0% positive
Latest IV / EM
108%
EM ±15.0% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-9.62$-7.31$-5.00$-2.69$-0.38 Actual $-7.53Actual $-9.62Actual $-3.53Actual $-0.40Actual $-0.38Actual $-0.53Est $-0.55Actual $-0.53Actual $-0.59Actual $-1.32Est $-1.10 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-41M$-31M$-20M$-9M$2M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-1.32 $-1.10 -20.0% -149.1% -0.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.59 financials
Mon Jun 30, 2025Jun 2025 $-0.53 financials
Wed May 7, 2025Mar/2025 $-0.53 $-0.55 +3.6% -2.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.38 financials
Sun Jun 30, 2024Jun 2024 $-0.40 financials
Sun Mar 31, 2024Mar 2024 $-3.53 financials
Sat Sep 30, 2023Sep 2023 $-9.62 financials
Fri Jun 30, 2023Jun 2023 $-7.53 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$2M$0
Cost of revenue$1M$0
Gross profit
Operating income$-44M$-19M$-17M$-17M$-13M$-14M
Net income$-41M$-17M$-15M$-15M$-10M$-10M
EPS (diluted)$-1.32$-0.59$-0.53$-0.53$-0.38$-0.40

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$25M$25M$25M$38M$23M$20M$41M$84M
Inventory$3M$3M$949,000$0
Total current assets$268M$301M$207M$214M$198M$212M$221M$199M
Total assets$273M$306M$211M$217M$201M$215M$224M$203M
Long-term debt
Total liabilities$26M$22M$17M$11M$9M$11M$9M$10M
Total equity$246M$284M$194M$206M$192M$204M$215M$193M

Implied volatility — last 90 days

103%105%108%110%113% Jun 07 — IV 108% · EM ±15.0%

Sector peers